Does anyone have any knowledge of the commercial consequences of ACL marketing an oral formulation of Fonda.
As I understand it, ACL is working with Emisphere to develop an oral formulation for use in out patient settings.
Assuming that eventually an oral formulation is approved and marketed, will the marketing process and revenues be through Emisphere at the exclusion of Dr Reddys?
oral fonda formulation
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable